MCAM-overexpressing breast cancer cells exhibit increased expression of Slug and downregulation of ERα, suggesting that the MCAM/Slug/ERα axis may contribute to tamoxifen resistance in ERα-negative breast cancer [140]. This evidence concerns the gene SNAI2 and breast cancer.